CF
PAHC icon

Corebridge Financial’s Phibro Animal Health PAHC Stock Holding History

Corebridge Financial’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,662
Closed -$228K – 1959
2025
Q1 		$228K Sell
10,662
-209
-2% -$4.67K ﹤0.01% 1994
2024
Q4 		$228K Sell
10,871
-848
-7% -$19.6K ﹤0.01% 2099
2024
Q3 		$264K Sell
11,719
-124
-1% -$2.39K ﹤0.01% 2062
2024
Q2 		$199K Buy
+11,843
New +$190K ﹤0.01% 2200

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Corebridge Financial's PAHC Position: Q2 2025 in Review

Corebridge Financial sold out of Phibro Animal Health (PAHC) in Q2 2025, closing a stake of 10,662 shares — an estimated $228K sold.

Corebridge Financial first reported a position in PAHC in Q2 2024 and held it in 4 quarters. The position peaked at $264K in Q3 2024. 194 funds tracked by Wall St. Rank hold PAHC as of Q2 2025.

  • Corebridge Financial reported no remaining Phibro Animal Health position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 10,662 Phibro Animal Health shares in Q2 2025, an estimated $228K.
  • Corebridge Financial first reported a position in Phibro Animal Health in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Phibro Animal Health position peaked at $264K in Q3 2024.
  • 194 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.